Back to Search
Start Over
BioCity Biopharma doses first patient in BC3195 Phase 1a/1b clinical trial in China
- Source :
- M2 Pharma. July 20, 2023
- Publication Year :
- 2023
-
Abstract
- M2 PHARMA-July 20, 2023-BioCity Biopharma doses first patient in BC3195 Phase 1a/1b clinical trial in China (C)2023 M2 COMMUNICATIONS BioCity Biopharma, a China-based clinical-stage biopharmaceutical company, announced on Wednesday that [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.757807417